Advanced Human Imaging (AHI) Announces Partnership with Activate Health OÜ

January 26, 2022 9:04 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Advanced Human Imaging Limited (NASDAQ: AHI) is pleased to announce the signing of a binding term sheet with Activate Health OÜ ("Activate"), an Estonia-based digital health provider.

Activate is developing a digital therapeutic platform for the prevention and early intervention of metabolic syndrome, a silent epidemic that effects nearly a third of the world's adult population. The digital therapeutic platform will provide patients and specialists with the necessary tools to address metabolic syndrome and delay the onset of chronic diseases such as cardiovascular disease and type 2 diabetes.

Activate will integrate the AHI MultiScan Software Development Kit into its proprietary digital therapeutic platform. The integration will empower users of the Activate platform to track and ascertain dimensional-based risk assessments, vital signs and identify chronic disease risk. These data points will be used to support and improve Activate health audits, targeted micro-programs, and on-demand appointments with healthcare specialists.

"We are delighted to be involved with such an innovative company that is based in the most progressive and advanced digital health ecosystem in the world, Estonia," said Vlado Bosanac, Chief Executive Officer of Advanced Human Imaging. "Our MultiScan solution enables our partners to intervene and assist their users early. Not only does this result in better health outcomes, but it improves the cost-effectiveness and facilitates the transition to preventive, rather than curative, medicine. We look forward to making a positive impact on Europeans' longevity of life, health and wellbeing."

Siim Saare, Founder and Chief Executive Officer of Activate Health, commented: "We are extremely excited to be working with AHI and to integrate their solution into the Activate platform application. The AHI technology will assist in the development of the novel health risk prediction model and AI-driven decision support system for the prevention and early intervention of chronic disease."

In January 2022 Activate was awarded a grant by Enterprise Estonia to expand their digital health footprint. This grant will assist in the acceleration of the integration of the AHI MultiScan digital health solution.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Related Entities